Midodrine-induced vascular ischemia in a hemodialysis patient: A case report and literature review

Sofia Rubinstein; Moshe Haimov; Michael J. Ross

doi:10.1080/08860220802249025

Midodrine-induced vascular ischemia in a hemodialysis patient: A case report and literature review

Sofia Rubinstein, Moshe Haimov, Michael J. Ross

Research output: Contribution to journal › Article › peer-review

13 Scopus citations

Abstract

Midodrine is an alpha-agonist that causes peripheral vasoconstriction, resulting in increased blood pressure. It has been reported to be safe and effective in patients with end stage renal disease (ESRD) and is widely used for hemodialysis-associated hypotension. We report a case report of midodrine-induced ischemia in a patient on hemodialysis and review the literature relating to the safety of midodrine in patients with end stage renal disease.

Original language	English (US)
Pages (from-to)	808-812
Number of pages	5
Journal	Renal Failure
Volume	30
Issue number	8
DOIs	https://doi.org/10.1080/08860220802249025
State	Published - Sep 2008
Externally published	Yes

Keywords

Hemodialysis-associated hypotension
Midodrine
Vascular ischemia

ASJC Scopus subject areas

Critical Care and Intensive Care Medicine
Nephrology

Access to Document

10.1080/08860220802249025

Cite this

@article{2367384f8d8740d591dca7d3f71b5704,

title = "Midodrine-induced vascular ischemia in a hemodialysis patient: A case report and literature review",

abstract = "Midodrine is an alpha-agonist that causes peripheral vasoconstriction, resulting in increased blood pressure. It has been reported to be safe and effective in patients with end stage renal disease (ESRD) and is widely used for hemodialysis-associated hypotension. We report a case report of midodrine-induced ischemia in a patient on hemodialysis and review the literature relating to the safety of midodrine in patients with end stage renal disease.",

keywords = "Hemodialysis-associated hypotension, Midodrine, Vascular ischemia",

author = "Sofia Rubinstein and Moshe Haimov and Ross, {Michael J.}",

year = "2008",

month = sep,

doi = "10.1080/08860220802249025",

language = "English (US)",

volume = "30",

pages = "808--812",

journal = "Renal Failure",

issn = "0886-022X",

publisher = "Informa Healthcare",

number = "8",

}

TY - JOUR

T1 - Midodrine-induced vascular ischemia in a hemodialysis patient

T2 - A case report and literature review

AU - Rubinstein, Sofia

AU - Haimov, Moshe

AU - Ross, Michael J.

PY - 2008/9

Y1 - 2008/9

N2 - Midodrine is an alpha-agonist that causes peripheral vasoconstriction, resulting in increased blood pressure. It has been reported to be safe and effective in patients with end stage renal disease (ESRD) and is widely used for hemodialysis-associated hypotension. We report a case report of midodrine-induced ischemia in a patient on hemodialysis and review the literature relating to the safety of midodrine in patients with end stage renal disease.

AB - Midodrine is an alpha-agonist that causes peripheral vasoconstriction, resulting in increased blood pressure. It has been reported to be safe and effective in patients with end stage renal disease (ESRD) and is widely used for hemodialysis-associated hypotension. We report a case report of midodrine-induced ischemia in a patient on hemodialysis and review the literature relating to the safety of midodrine in patients with end stage renal disease.

KW - Hemodialysis-associated hypotension

KW - Midodrine

KW - Vascular ischemia

UR - http://www.scopus.com/inward/record.url?scp=51849122052&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=51849122052&partnerID=8YFLogxK

U2 - 10.1080/08860220802249025

DO - 10.1080/08860220802249025

M3 - Article

C2 - 18791956

AN - SCOPUS:51849122052

SN - 0886-022X

VL - 30

SP - 808

EP - 812

JO - Renal Failure

JF - Renal Failure

IS - 8

ER -

Midodrine-induced vascular ischemia in a hemodialysis patient: A case report and literature review

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this